Skip to main content
Clinical Trials/TCTR20210705005
TCTR20210705005
Not yet recruiting
Phase 2

Changes in Brain Glucose Metabolism as Evaluated by F-18 FDG PET/CT in Autistic Patients after Transcranial Direct Current Stimulation, Non Randomized Controlled trial

Research and service institute for autism0 sites8 target enrollmentJuly 5, 2021

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Autism Spectrum Disorder
Sponsor
Research and service institute for autism
Enrollment
8
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 5, 2021
End Date
July 14, 2021
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Research and service institute for autism

Eligibility Criteria

Inclusion Criteria

  • (a) mild to moderate autistic symptoms (CARS score 30\-36\.5\) which could stay still in the scanner;
  • (b) aged between 15 and 30;
  • (c) the caregiver consents to participate in the research and can follow up the stimulation results;
  • (d) a healthy volunteer aged between 15 and 30\.

Exclusion Criteria

  • (a) wound or skin abrasion at the area under electrode; (b) on metallic device; (c) skull defect; (d) severe neurological disorders such as brain tumor, intracranial infection; (e) drug abuse; (f) uncooperative parents and caregivers; (f) uncontrollable epilepsy; (g) use of herbal remedies and other alternative therapies such as craniosacral manipulation or hyperbaric oxygen therapy; and (h) claustrophobia

Outcomes

Primary Outcomes

Not specified

Similar Trials